← Leaderboards
Oren Shalom Rom
University Of Michigan At Ann Arbor
$3,844,260
Attributed
$3,844,260
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,844,260 · 4
By mechanism
R01$2,890,550 · 2
R00$747,000 · 1
K99$206,710 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Joseph Holoshitz$13,104,321
- Anna Vachaparampil Mathew$1,341,698
- Linda M McAllister-Lucas$4,836,096
- Peter C Lucas$14,854,904
- Yuqing E Chen$44,993,151
Others in their field
Other Emerging Leaders on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Susan M Landau · University Of California Berkeley$47,252,026
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,835,254
- Bradley G Hammill · Duke University$15,773,864
Research focus
Cardiovascular DiseasesHepaticTranscriptomicsAtherosclerosisRisk FactorsCause Of DeathLinkPathway InteractionsLipidsFatty LiverGenome Wide Association StudySamplingNon-Alcoholic Fatty Liver DiseaseGenesCardiometabolic DiseaseGeneticMortalityLiverMetabolic PathwayMetabolomicsNon-Insulin-Dependent Diabetes MellitusAutomobile DrivingMacrophageAmino Acids
Grant awards (12)
Lipidated Amino Acids in Cardiometabolic Diseases$429,581
R01 · FY2025 · DK · contact PI
Dysregulated Oxalate Metabolism in Cardiometabolic Diseases$428,730
R01 · FY2025 · DK · contact PI
Lipidated Amino Acids in Cardiometabolic Diseases$412,398
R01 · FY2024 · DK · contact PI
Dysregulated Oxalate Metabolism in Cardiometabolic Diseases$411,581
R01 · FY2024 · DK · contact PI
Lipidated Amino Acids in Cardiometabolic Diseases$452,581
R01 · FY2023 · DK · contact PI
Dysregulated Oxalate Metabolism in Cardiometabolic Diseases$428,730
R01 · FY2023 · DK · contact PI
Mechanisms of glycine-based therapy for atherosclerosis$249,000
R00 · FY2023 · HL · contact PI
Lipidated Amino Acids in Cardiometabolic Diseases$326,949
R01 · FY2022 · DK · contact PI
Mechanisms of glycine-based therapy for atherosclerosis$249,000
R00 · FY2022 · HL · contact PI
Mechanisms of glycine-based therapy for atherosclerosis$249,000
R00 · FY2021 · HL · contact PI
Mechanisms of glycine-based therapy for atherosclerosis$103,355
K99 · FY2021 · HL · contact PI
Mechanisms of glycine-based therapy for atherosclerosis$103,355
K99 · FY2020 · HL · contact PI